MYC Induced Nuclear Antigen (MINA) (N-Term) Peptide
MINA
Reactivity: Human
BP
Sodium azide
-
- Target See all MINA products
- MINA (MYC Induced Nuclear Antigen (MINA))
- Protein Region
- N-Term
- Origin
- Human
- Application
- Blocking Peptide (BP)
- Characteristics
-
15 amino acids near the amino terminus of human MINA.
Human
-
-
- Application Notes
- MINA peptide is used for blocking the activity of MINA.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 200 μg/mL
- Buffer
- PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
- Preservative
- Sodium azide
- Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
- Expiry Date
- 12 months
-
- Target
- MINA (MYC Induced Nuclear Antigen (MINA))
- Synonyms
- MDIG Peptide, MINA53 Peptide, NO52 Peptide, ROX Peptide, 1810047J07Rik Peptide, 2410057H13Rik Peptide, 3830408E23Rik Peptide, AI449204 Peptide, Mina53 Peptide, mina Peptide, MGC83527 Peptide, MINA Peptide, DKFZp459K0725 Peptide, Mina Peptide, ribosomal oxygenase 2 Peptide, MYC induced nuclear antigen Peptide, ribosomal oxygenase 2 L homeolog Peptide, RIOX2 Peptide, Riox2 Peptide, MINA Peptide, riox2.L Peptide, riox2 Peptide
-
You are here:
